US 11891389
PGDH inhibitors and methods of making and using
granted A61KA61K31/4184A61K31/437
Quick answer
US patent 11891389 (PGDH inhibitors and methods of making and using) held by Myoforte Therapeutics, Inc. expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Myoforte Therapeutics, Inc.
- Grant date
- Tue Feb 06 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/4184, A61K31/437, A61K31/4453, A61K31/454